Exploring Developing Biomarkers Based On Early Autonomic Dysfunction In Movement Disorders
If you are looking for information about Developing Biomarkers Based On Early Autonomic Dysfunction In Movement Disorders, you have come to the right place.
- Chad Christine, MD Conference on Parkinson's
- Mitchell Miglis, MD, Stanford Health Care, Stanford, CA, shares guidance for the treatment of
- Michael Ugrumov, MD, PhD, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia, talks on ...
- Mitchell Miglis, MD, Clinical Assistant Professor of
- Dr. Brent Goodman, Director of the
In-Depth Information on Developing Biomarkers Based On Early Autonomic Dysfunction In Movement Disorders
Mitchell Miglis, MD, Stanford Health Care, Stanford, CA, discusses the significance of Dr. Jason Crowell talks with Prof. Bastiaan Bloem about the latest developments in Prodromal James Rowe, PhD, University of Cambridge, Cambridge, UK, discusses
Autonomic dysfunction
We hope this detailed breakdown of Developing Biomarkers Based On Early Autonomic Dysfunction In Movement Disorders was helpful.
